Celyad Oncology SA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 2007-01-01

Employees: 51

Market Cap: -

Website: http://www.celyad.com

Clinical Trials

Active:1

Completed:4

Trial Phases

3 Phases

Phase 1:10

Phase 2:1

Phase 3:2

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials

Phase 1

10 (76.9%)

Phase 3

2 (15.4%)

Phase 2

1 (7.7%)

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

Phase 1

Recruiting

Conditions: Unresectable Metastatic Colorectal Cancer

Interventions: Drug: CYAD-101
Drug: FOLFOX
Drug: Pembrolizumab

First Posted Date: 2021-08-05

Last Posted Date: 2022-03-09

Lead Sponsor: Celyad Oncology SA

Target Recruit Count: 34

Registration Number: NCT04991948

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸
Moffit Cancer Center, Tampa, Florida, United States
🇧🇪
UZ Antwerpen, Edegem, Belgium

and more 2 locations

Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1

Active, not recruiting

Conditions: Relapse/Refractory Multiple Myeloma

Interventions: Biological: CYAD-211
Drug: Endoxan
Drug: Fludara

First Posted Date: 2020-11-03

Last Posted Date: 2023-08-31

Lead Sponsor: Celyad Oncology SA

Target Recruit Count: 18

Registration Number: NCT04613557

Locations: 🇺🇸
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
Nyu Langone Hospitals, New York, New York, United States
🇧🇪
Universitair Ziekenhuis Antwerpen, Antwerp, Belgium

and more 2 locations

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

Phase 1

Recruiting

Conditions: Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions: Biological: CYAD-02
Drug: ENDOXAN
Drug: Fludara

First Posted Date: 2019-11-19

Last Posted Date: 2020-06-09

Lead Sponsor: Celyad Oncology SA

Target Recruit Count: 27

Registration Number: NCT04167696

Locations: 🇺🇸
Mayo Clinic Cancer Center, Jacksonville, Florida, United States
🇺🇸
University of Kansas Cancer Center, Fairway, Kansas, United States
🇧🇪
Uz Leuven, Leuven, Belgium

and more 2 locations